The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
about
Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicThe HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabineTargeting Hsp90 and its co-chaperones to treat Alzheimer's diseaseExperience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma.Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.
P2860
The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The HSP90 inhibitor NVP-AUY922 ...... acute myeloid leukaemia cells.
@en
The HSP90 inhibitor NVP-AUY922 ...... acute myeloid leukaemia cells.
@nl
type
label
The HSP90 inhibitor NVP-AUY922 ...... acute myeloid leukaemia cells.
@en
The HSP90 inhibitor NVP-AUY922 ...... acute myeloid leukaemia cells.
@nl
prefLabel
The HSP90 inhibitor NVP-AUY922 ...... acute myeloid leukaemia cells.
@en
The HSP90 inhibitor NVP-AUY922 ...... acute myeloid leukaemia cells.
@nl
P2093
P2860
P356
P1476
The HSP90 inhibitor NVP-AUY922 ...... acute myeloid leukaemia cells.
@en
P2093
Alan K Burnett
Chris J Pepper
Elisabeth J Walsby
Michelle Lazenby
Steven Knapper
P2860
P356
10.1111/BJH.12215
P407
P577
2013-01-29T00:00:00Z